Natural Alternatives International (NASDAQ:NAII) spotted trading -39.53% off 52-week high price. On the other end, the stock has been noted 41.83% away from the low price over the last 52-weeks. The stock changed -0.49% to recent value of $6.74. The stock transacted 4384 shares during most recent day however it has an average volume of 12.42K shares. The company has 6.57M of outstanding shares and 5.14M shares were floated in the market.
On Sept. 21, 2020, Natural Alternatives International (NASDAQ:NAII) a leading formulator, manufacturer and marketer of customized nutritional supplements, released financial operating results for the fourth quarter and fiscal year ended June 30, 2020.
Consolidated net sales during the three months ended June 30, 2020, increased $4.8 million, or 16%, from $30.3 million recorded in the comparable prior year period. For the quarter ended June 30, 2020, private-label contract manufacturing sales increased $5.7 million, or 21%, from the comparable quarter last year. CarnoSyn® beta-alanine licensing and raw material sales decreased 28% to $2.3 million during the fourth quarter of fiscal year 2020, as compared to $3.2 million for the fourth quarter of fiscal 2019. Net income was $1.8 million, or $0.27 per diluted share, for the fourth quarter of fiscal year 2020, compared to a net loss of $0.02 million, or $0.03 per diluted share, in the fourth quarter of fiscal year 2019.
Consolidated net sales during fiscal 2020 decreased $19.4 million, or 14%, from $138.3 million recorded in fiscal 2019. For fiscal 2020, private-label contract manufacturing sales decreased $15.3 million, or 13%, from the comparable period last year. A majority of this decline occurred during the first nine months of fiscal 2020 while the fourth quarter of fiscal 2020 included a year over year increase.
Its earnings per share (EPS) expected to touch remained -21.30% for this year. NAII has a gross margin of 14.00% and an operating margin of -3.80% while its profit margin remained -3.20% for the last 12 months.
According to the most recent quarter its current ratio was 3 that represents company’s ability to meet its current financial obligations. The price moved ahead of -10.01% from the mean of 20 days, -6.27% from mean of 50 days SMA and performed -6.80% from mean of 200 days price. Company’s performance for the week was -6.04%, -13.52% for month and YTD performance remained -15.58%.